megestrol acetate has been researched along with medroxyprogesterone acetate in 80 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (23.75) | 18.7374 |
| 1990's | 19 (23.75) | 18.2507 |
| 2000's | 23 (28.75) | 29.6817 |
| 2010's | 15 (18.75) | 24.3611 |
| 2020's | 4 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kollman, PA; Lee, DL; Marsh, FJ; Wolff, ME | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Cooper, L; Hart, BL | 1 |
| Larsen, M; Pors, H; Sørensen, OS; von Eyben, FE | 1 |
| Labrie, C; Labrie, F; Pelletier, G; Simard, J; Zhao, HF | 1 |
| Sleijfer, DT; Tjabbes, T; van der Ploeg, E; van Veelen, H; Willemse, PH | 1 |
| Dikkeschei, LD; Sleijfer, DT; Tjabbes, T; van Veelen, H; Willemse, PH | 1 |
| Lundgren, S; Lønning, PE | 1 |
| Okada, H; Yamamoto, T | 1 |
| Abrams, JS; Aisner, J; Parnes, H | 1 |
| Cusan, L; Labrie, C; Labrie, F; Lapointe, S; Plante, M | 1 |
| Labrie, F; Lapointe, S; Plante, M | 1 |
| Kvinnsland, S; Lundgren, S; Utaaker, E | 1 |
| Carpenter, JT | 1 |
| Blackledge, GR; Latief, T; Morrison, M; Mould, JJ; Spooner, D | 1 |
| Bakke, O; Kvinnsland, S; Lundgren, S; Ueland, PM; Utaaker, E | 1 |
| Bönisch, E; Gärtner, E; Hartlapp, J; Kleeberg, UR; Nagel, GA; Scherpe, A; Wander, HE | 1 |
| Becher, R; Miller, AA; Schmidt, CG | 1 |
| Kvinnsland, S; Lönning, PE; Lundgren, S; Wiedemann, G | 1 |
| Glick, JH; Haller, DG | 1 |
| Presl, J | 1 |
| Blumenschein, GR | 1 |
| Adlercreutz, H; Hämäläinen, EK; Korpela, JT; Pulkkinen, MO | 1 |
| Hellenäs, KE; Rosén, J; Shearan, P; Törnqvist, P | 1 |
| Burger, CW; Greggi, S; Kenemans, P; van der Vange, N; Vermorken, JB | 1 |
| Baker, TR; Cornelison, TL; Driscoll, DL; Piver, MS | 1 |
| Espie, M | 1 |
| Cohen, JD; Robins, HI | 1 |
| England, GC | 1 |
| Hyder, SM; Murthy, L; Stancel, GM | 1 |
| Beckurts, T; Heidecke, CD; Kunz, S; Schwarz, LR; Werner, S; Wolff, T | 1 |
| Ghiani, M; Lai, P; Macciò, A; Mantovani, G; Massa, E; Santona, MC | 2 |
| Kissner, DG | 1 |
| Amezcua, CA; Felix, JC; Lu, JJ; Stanczyk, FZ; Zheng, W | 1 |
| Mantovani, G | 1 |
| Fowler, R; Imrie, K | 1 |
| Emons, G; Hinney, B; Huschmand, H; Krauss, T; Viereck, V | 1 |
| Bergaglio, M; Bertelli, G; Biglia, N; Costantini, M; Del Mastro, L; Porcile, G; Pronzato, P; Rosso, R; Sismondi, P; Venturini, M; Venturini, S | 1 |
| D'arcangues, C | 1 |
| Applezweig, N | 1 |
| Koffel, JC | 1 |
| Prous, JR; Sussmann, AR | 1 |
| Fekete, G | 1 |
| Rozenbaum, H | 1 |
| Baum, N | 1 |
| Antonietti, C; Gilli, G; Lelli, G; Montanari, M; Scapoli, D | 1 |
| Aksu, T; Ayhan, A; Bozdag, G; Yarali, H | 1 |
| Herzog, TJ | 1 |
| Aoki, D; Banno, K; Nozawa, S; Susumu, N; Suzuki, A; Suzuki, N; Tamada, Y | 1 |
| Gorbunova, VA; Howell, A; Lichinitser, MR; Pienkowski, T; Robertson, JF; Watanabe, T | 1 |
| Frumovitz, M; Gershenson, DM | 1 |
| Cheung, KL; Owers, R; Robertson, JF | 1 |
| Aydiner, A; Karagol, H; Kucucuk, S; Saip, P; Topuz, E; Uygun, K | 1 |
| Mortensen, SK; Pedersen, M | 1 |
| Kender, T; Lõhmus, M | 1 |
| Contu, P; Deiana, L; Dessì, M; Floris, C; Gramignano, G; Macciò, A; Madeddu, C; Mantovani, G; Massa, E; Panzone, F; Sanna, E; Serpe, R; Tanca, FM | 1 |
| Jonsson, H; Kemetli, L; Lenner, P; Nyström, L; Rutqvist, LE; Törnberg, S | 1 |
| Han, AR; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Kwon, YS; Nam, JH | 1 |
| Huo, Z; Lang, JH; Shen, K; Wu, M; Yang, JX; Yu, M | 1 |
| Hahn, HS; Hong, JS; Hong, SR; Kim, TJ; Kwon, YS; Lee, IH; Lee, KH; Lim, JY; Lim, KT; Mok, JE; Park, SJ; Shim, JU; Yoon, SG | 1 |
| Chen, Y; Lv, W; Mao, Y; Wan, X; Xie, X | 1 |
| Kim, JY; Park, CT; Park, H; Seok, JM; Seong, SJ; Shim, JY; Yoon, BS | 1 |
| Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, KR; Kim, SM; Kim, TJ; Kim, YM; Kim, YT; Nam, JH; Park, JY; Seong, SJ | 1 |
| Bae, DS; Kim, JW; Kim, SM; Kim, TJ; Nam, JH; Park, JY; Seong, SJ | 1 |
| Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, TJ; Kim, YM; Kim, YT; Lee, SH; Nam, JH; Park, JY; Seong, SJ | 1 |
| Chang, CW; Wang, SN; Wei, RJ; Yeh, YT | 1 |
| Bing, S; Lijuan, D; Santai, S; Shaohua, Z; Shikai, W; Tao, W; Xiangying, M; Xin, Z; Yan, M; Yue, W; Zefei, J | 1 |
| Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, TJ; Kim, YM; Kim, YT; Nam, JH; Park, JY | 1 |
| Clarke, BA; Feigenberg, T; Ferguson, SE; Gien, LT; Ismiil, N; Laframboise, S; Massey, C; Simpson, AN | 1 |
| Bi, Y; Chen, M; Jin, Y; Li, Y; Pan, L; Shan, Y | 1 |
| Franco, EL; Gotlieb, WH; Greenwald, ZR; Huang, LN; Wissing, MD | 1 |
| Li, L; Lin, J; Lou, H; Wang, F; Xu, H; Yu, A; Yu, H; Zhang, X | 1 |
| Chung, YS; Kim, S; Kim, SW; Kim, YT; Lee, JY; Nam, EJ; Park, E; Woo, HY | 1 |
| He, Y; Wang, J; Wang, Y; Zhou, R | 1 |
| Cho, A; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, SW; Park, JY; Suh, DS | 1 |
| Ascione, M; Bifulco, G; Boccia, D; Buonfantino, C; Cafasso, V; De Angelis, MC; Della Corte, L; Giampaolino, P; Grasso, G; Gullo, G; Mercorio, A; Palumbo, M; Serafino, P; Verrazzo, P; Viciglione, F | 1 |
11 review(s) available for megestrol acetate and medroxyprogesterone acetate
| Article | Year |
|---|---|
[Therapy of advanced endometrial cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Prognosis; Uterine Neoplasms | 1990 |
Current status of high-dose progestins in breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Progesterone Congeners | 1990 |
Progestational agents in the treatment of breast cancer.
Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Norethindrone; Norethindrone Acetate; Progestins | 1988 |
Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.
Topics: Anorexia; Appetite Stimulants; Cachexia; Cytokines; Humans; Interleukin-1; Interleukin-6; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasms; Progesterone Congeners; Tumor Necrosis Factor-alpha; Wasting Syndrome | 1998 |
Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms.
Topics: Anorexia; Antineoplastic Agents; Appetite Stimulants; Cachexia; Clinical Trials as Topic; Cytokines; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Proteins; Neoplasms; Progesterone Congeners; Serotonin | 1998 |
[Hormonal therapy and chemotherapy of endometrial cancer].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Staging; Palliative Care | 2002 |
Treatment of the cancer anorexia-cachexia syndrome: a critical reappraisal.
Topics: Anorexia; Cachexia; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Metoclopramide; Neoplasms; Prognosis; Risk Assessment; Severity of Illness Index; Survival Analysis; Terminally Ill; Treatment Outcome; Wasting Syndrome | 2003 |
[Conservative hormonal therapy for endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasm Staging; Treatment Outcome | 2004 |
Fertility-sparing therapy for young women with endometrial cancer.
Topics: Adult; Age of Onset; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Patient Selection; Pregnancy; Pregnancy Outcome; Prognosis | 2006 |
Progesterone and related compounds in hepatocellular carcinoma: basic and clinical aspects.
Topics: Androgens; Antineoplastic Agents, Hormonal; Carcinoma, Hepatocellular; Estrogens; Female; Humans; Liver Neoplasms; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Sex Characteristics | 2013 |
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Ki-67 Antigen; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; NF-E2-Related Factor 2; Pregnancy; Progestins; Survivin | 2022 |
10 trial(s) available for megestrol acetate and medroxyprogesterone acetate
| Article | Year |
|---|---|
Comparison of diazepam with progestin for effectiveness in suppression of urine spraying behavior in cats.
Topics: Animals; Appetite; Ataxia; Behavior, Animal; Cat Diseases; Cats; Diazepam; Female; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Progestins; Recurrence; Sleep; Urination Disorders; Weight Gain | 1992 |
A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Randomized Controlled Trials as Topic | 1990 |
Adrenal steroids as parameters of the bioavailability of MA and MPA.
Topics: Adrenal Cortex Hormones; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate | 1990 |
Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--II. A differential effect of megestrol acetate and medroxyprogesterone acetate on serum estrone sulfate and sex hormone binding globulin.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Estradiol; Estrone; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Sex Hormone-Binding Globulin | 1990 |
[Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation | 1987 |
Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Topics: Adult; Contraceptive Agents, Female; Erythromycin; Estradiol; Estrone; Ethinyl Estradiol; Feces; Female; Humans; Intestines; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Norethindrone; Oxytetracycline; Trimethoprim | 1984 |
Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Melphalan; Middle Aged; Prospective Studies; Survival Rate | 1995 |
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study.
Topics: Administration, Oral; Aged; Breast Neoplasms; Chi-Square Distribution; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hot Flashes; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Patient Satisfaction; Postmenopause; Probability; Reference Values; Severity of Illness Index; Treatment Outcome | 2002 |
Endocrine response after prior treatment with fulvestrant in postmenopausal women with advanced breast cancer: experience from a single centre.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Postmenopause; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Tamoxifen; Treatment Outcome | 2006 |
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antioxidants; Appetite Stimulants; Ascorbic Acid; Basal Metabolism; Cachexia; Carnitine; Dietary Supplements; Exercise; Fatigue; Female; Humans; Interleukin-6; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Muscle Proteins; Neoplasms; Nutritional Support; Oxidative Stress; Treatment Outcome; Tumor Necrosis Factor-alpha; Vitamin A; Vitamin E | 2008 |
59 other study(ies) available for megestrol acetate and medroxyprogesterone acetate
| Article | Year |
|---|---|
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
Topics: Androstenes; Animals; Guinea Pigs; Humans; Hydroxyprogesterones; Protein Binding; Rabbits; Receptors, Progesterone; Sheep; Steroids; Structure-Activity Relationship | 1977 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Longterm remission of multiple brain metastases with tamoxifen.
Topics: Activities of Daily Living; Aged; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Estrogens; Female; Humans; Mastectomy, Radical; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Palliative Care; Psychomotor Disorders; Tamoxifen | 1991 |
Synthetic progestins stimulate prostatic binding protein messenger RNAs in the rat ventral prostate.
Topics: Androgen-Binding Protein; Animals; Cyproterone; Cyproterone Acetate; DNA Probes; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Nucleic Acid Hybridization; Progesterone Congeners; Prostate; Prostatein; Rats; Rats, Inbred Strains; RNA, Messenger; Secretoglobins; Testosterone Congeners; Uteroglobin | 1990 |
Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
Topics: Adrenal Glands; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Organ Size; Ornithine Decarboxylase; Progesterone Congeners; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Spironolactone | 1987 |
Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice.
Topics: Androgens; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Female; Flutamide; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Mice; Progesterone Congeners; Prostatic Neoplasms | 1988 |
Oral high-dose progestins as treatment for advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Retrospective Studies | 1989 |
Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: relationship of response to previous treatment.
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged | 1986 |
Effect of oral high-dose progestins on the disposition of antipyrine, digitoxin, and warfarin in patients with advanced breast cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antipyrine; Breast Neoplasms; Digitoxin; Female; Humans; Kinetics; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Progesterone Congeners; Warfarin | 1986 |
Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer.
Topics: Aged; Breast Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Radioimmunoassay | 1988 |
[Which hormone therapy should be used in advanced breast carcinoma in males?].
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Axilla; Breast Neoplasms; Dexamethasone; Drug Evaluation; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Tamoxifen; Testolactone; Testosterone Congeners | 1988 |
Progestational agents in advanced breast cancer: an overview.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Menopause; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Cell Surface; Tamoxifen | 1986 |
[Gestagens and the treatment of hot flushes in the postmenopausal period].
Topics: Climacteric; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate | 1983 |
The role of progestins in the treatment of breast cancer.
Topics: Breast Neoplasms; Cell Line; Cytoplasm; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1983 |
Automated extraction of acetylgestagens from kidney fat by matrix solid phase dispersion.
Topics: Abattoirs; Adipose Tissue; Automation; Chlormadinone Acetate; Chromatography, High Pressure Liquid; Immunoenzyme Techniques; Kidney; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Radioisotope Dilution Technique; Reagent Kits, Diagnostic; Tritium | 1994 |
Experience with hormonal therapy in advanced epithelial ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Carcinoma; Estrogen Antagonists; Female; Flutamide; Gonadotropin-Releasing Hormone; Humans; Luteolytic Agents; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Progesterone Congeners; Remission Induction; Survival Rate; Tamoxifen; Triptorelin Pamoate | 1995 |
Megestrol acetate in advanced breast carcinoma.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Cross-Over Studies; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome | 1994 |
Response of "benign" metastasizing leiomyoma to progestin withdrawal. Case report.
Topics: Female; Humans; Leiomyoma; Lung Neoplasms; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Progesterone Congeners; Uterine Neoplasms | 1993 |
Effect of progestogens and androgens upon spermatogenesis and steroidogenesis in dogs.
Topics: Animals; Dogs; Drug Synergism; Esters; Luteinizing Hormone; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Semen; Sexual Behavior, Animal; Sperm Count; Sperm Motility; Spermatogenesis; Spermatozoa; Testosterone | 1997 |
Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Topics: Breast Neoplasms; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphokines; Medroxyprogesterone Acetate; Megestrol Acetate; Mifepristone; Neoplasm Proteins; Neovascularization, Pathologic; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Progestins; Receptors, Progesterone; Stimulation, Chemical; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Formation of DNA adducts by cyproterone acetate and some structural analogues in primary cultures of human hepatocytes.
Topics: Adult; Aged; Androgen Antagonists; Cells, Cultured; Chlormadinone Acetate; Cyproterone Acetate; DNA Adducts; Female; Humans; Liver; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Progesterone; Structure-Activity Relationship; Toxicity Tests | 1997 |
Role of progestational agents in the treatment of undernourished patients with cystic fibrosis.
Topics: Adolescent; Adult; Appetite Stimulants; Cystic Fibrosis; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Nutrition Disorders; Progesterone Congeners; Weight Gain | 2000 |
Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
Topics: Adult; Apoptosis; Cell Count; Endometrial Hyperplasia; Endometrium; Female; Humans; In Situ Nick-End Labeling; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Paraffin Embedding; Progesterone Congeners; Progestins; Tumor Cells, Cultured | 2000 |
Cachexia and anorexia.
Topics: Anorexia; Cachexia; Cytokines; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasms; Progesterone Congeners | 2000 |
Thalidomide-associated hepatitis: a case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Dexamethasone; Doxorubicin; Estrogens, Conjugated (USP); Fatal Outcome; Female; Hepatitis C; Humans; Leukemia, Plasma Cell; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Salvage Therapy; Thalidomide; Thrombocytopenia; Vincristine | 2001 |
Once-a-month estrogen/progestogen injectables.
Topics: Amenorrhea; Asia; Asia, Eastern; Biology; Blood; Blood Coagulation; Carbohydrates; China; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Developing Countries; Disease; Endocrine System; Endometrium; Family Planning Services; Fibrinolysis; Genitalia; Genitalia, Female; Glucose; Hemorrhage; Hormones; Injections; International Agencies; Lipids; Medroxyprogesterone Acetate; Megestrol Acetate; Menstruation Disturbances; Metabolism; Norethindrone; Organizations; Ovulation; Patient Acceptance of Health Care; Physiology; Progesterone; Progestins; Reproduction; Research; Signs and Symptoms; United Nations; Urogenital System; Uterus; World Health Organization | 1991 |
Steroids.
Topics: Adrenal Cortex Hormones; Africa; Americas; Asia; Biology; Chlormadinone Acetate; Contraception; Contraceptives, Oral; Developed Countries; Developing Countries; Dimethisterone; Economics; Endocrine System; Estradiol; Ethynodiol Diacetate; Europe; Europe, Eastern; Family Planning Services; Germany, West; Hormones; Italy; Latin America; Medroxyprogesterone Acetate; Megestrol Acetate; Mestranol; Mexico; Netherlands; Norethindrone; Norethynodrel; Norgestrel; North America; Physiology; Progesterone; Progestins; Research; Switzerland; Technology; Testosterone; United Kingdom; United States | 1969 |
[Pills and minipills].
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Disease; Estrogens; Ethinyl Estradiol; Family Planning Services; Injections; Medroxyprogesterone Acetate; Megestrol Acetate; Menstruation Disturbances; Mestranol; Progesterone Congeners | 1978 |
[Gas chromatography of oral progestagens and estrogens].
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Dimethisterone; Ethinyl Estradiol; Family Planning Services; Lynestrenol; Medroxyprogesterone Acetate; Megestrol Acetate; Mestranol; Norethindrone; Norgestrel | 1968 |
Chemistry, pharmacology and clinical pharmacology of oral contraceptives.
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Ethynodiol Diacetate; Family Planning Services; Lynestrenol; Medroxyprogesterone Acetate; Megestrol Acetate; Norethindrone; Norethynodrel | 1968 |
[What happens in our patients' bodies to the steroid hormones we prescribe? 2. Synthetic progestins].
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Ethynodiol Diacetate; Family Planning Services; Lynestrenol; Medroxyprogesterone Acetate; Megestrol Acetate; Norethindrone; Norgestrel | 1981 |
How to manage hot flashes in prostate cancer?
Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Belladonna Alkaloids; Diethylstilbestrol; Dose-Response Relationship, Drug; Drug Combinations; Ergotamines; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Methysergide; Middle Aged; Phenobarbital; Prostatic Neoplasms | 2003 |
A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Cesarean Section; Embryo Transfer; Endometrial Neoplasms; Female; Humans; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Progesterone; Sperm Injections, Intracytoplasmic; Ultrasonography | 2004 |
What is the clinical value of adding tamoxifen to progestins in the treatment [correction for treament] of advanced or recurrent endometrial cancer?
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Drug Synergism; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Receptors, Progesterone; Tamoxifen | 2004 |
Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Postmenopause; Retrospective Studies; Salvage Therapy; Tamoxifen; Treatment Outcome | 2005 |
Evaluation of prognostic factors and comparison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Paclitaxel; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2006 |
Confirmatory analysis of acetylgestagens in plasma using liquid chromatography-tandem mass spectrometry.
Topics: Animals; Cattle; Chemistry Techniques, Analytical; Chlormadinone Acetate; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Residues; Mass Spectrometry; Medroxyprogesterone Acetate; Megestrol Acetate; Melengestrol Acetate; Models, Chemical; Pregnanes; Swine | 2007 |
Determination of gestagens in kidney fat by liquid chromatography tandem mass spectrometry.
Topics: Calibration; Chemistry, Organic; Chlormadinone Acetate; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Kidney; Mass Spectrometry; Medroxyprogesterone Acetate; Megestrol Acetate; Melengestrol Acetate; Progestins; Reproducibility of Results; Sensitivity and Specificity; Solvents | 2007 |
Temporal trends in the use of adjuvant systemic therapy in breast cancer: a population based study in Sweden 1976-2005.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Goserelin; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Ovariectomy; Sweden; Tamoxifen | 2009 |
Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Dilatation and Curettage; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Reproductive Techniques, Assisted; Retrospective Studies | 2009 |
Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antineoplastic Agents, Hormonal; Cell Differentiation; Combined Modality Therapy; Endometrial Neoplasms; Endometrium; Female; Fertility; Follow-Up Studies; Humans; Hydroxyprogesterones; Hyperplasia; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Progestins; Remission Induction; Reproductive Techniques, Assisted; Retrospective Studies; Severity of Illness Index | 2009 |
Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.
Topics: Adult; Algorithms; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Follow-Up Studies; Gynecologic Surgical Procedures; Humans; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Progestins; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult | 2009 |
Outcomes of conservative therapy for young women with early endometrial adenocarcinoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome | 2010 |
Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Contraceptives, Oral, Hormonal; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Maintenance Chemotherapy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Retrospective Studies; Time Factors; Uterine Neoplasms; Young Adult | 2012 |
Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002).
Topics: Administration, Oral; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Cohort Studies; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Prognosis; Survival Rate; Young Adult | 2013 |
Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.
Topics: Abortion, Spontaneous; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Disease-Free Survival; Endometrial Neoplasms; Female; Fertility Agents; Humans; Infant, Newborn; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Neoplasm Staging; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Rate; Pregnancy, Ectopic; Premature Birth; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
Topics: Adenocarcinoma; Adult; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Progestins; Recurrence | 2013 |
Progestin as an alternative treatment option for multi-treated recurrent triple-negative breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2013 |
Hormonal therapy for women with stage IA endometrial cancer of all grades.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Cohort Studies; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Progestins; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult | 2013 |
Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysterectomy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Organ Sparing Treatments; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome | 2014 |
Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; China; Disease-Free Survival; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility; Fertility Preservation; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Obesity; Pregnancy; Progestins; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Cause of Death; Cohort Studies; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysterectomy; Kaplan-Meier Estimate; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Propensity Score; Proportional Hazards Models; SEER Program; Time Factors; United States | 2017 |
Fertility Preserved Hysteroscopic Approach for the Treatment of Stage Ia Endometrioid Carcinoma.
Topics: Adult; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Staging; Pregnancy; Retrospective Studies | 2017 |
Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Biomarkers; Biopsy; Disease Progression; DNA Mismatch Repair; DNA Polymerase II; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Hysterectomy; Intrauterine Devices, Medicated; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Mutation; Neoplasm Recurrence, Local; Prognosis; Receptors, Progesterone; Retrospective Studies; Tumor Suppressor Protein p53; Young Adult | 2021 |
Oncologic and obstetrical outcomes after fertility-preserving retreatment in patients with recurrent atypical endometrial hyperplasia and endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Retreatment; Retrospective Studies; Young Adult | 2020 |
Continued medical treatment for persistent early endometrial cancer in young women.
Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Biopsy; Carcinoma, Endometrioid; Disease-Free Survival; Drug Administration Schedule; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices; Levonorgestrel; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Myometrium; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prognosis; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome; Ultrasonography | 2021 |